Poniard Pharmaceuticals, Inc. (PARD)

Poniard Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2010	FY 2009	FY 2008	FY 2007	FY 2006
Period Ending	Jan 8, 2026	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008	Dec 31, 2007	Dec 31, 2006
Market Capitalization	0	25	77	67	153	114
Market Cap Growth	-99.78%	-67.24%	14.58%	-56.20%	34.02%	343.21%
Enterprise Value	-	16	57	10	67	65
Last Close Price	0.00	20.80	73.20	77.20	176.40	200.00
PB Ratio	0.00	2.97	3.24	1.41	1.72	2.43
P/TBV Ratio	-	12.12	4.78	1.72	1.93	3.20
Debt / Equity Ratio	0.53	0.19	0.86	0.53	0.12	0.30
Quick Ratio	0.67	2.68	2.53	3.80	9.78	4.40
Current Ratio	0.76	3.23	2.60	3.87	9.91	4.47
Return on Equity (ROE)	-210.37%	-187.25%	-128.25%	-71.03%	-48.21%	-93.06%
Return on Assets (ROA)	-46.03%	-48.99%	-37.44%	-32.45%	-25.44%	-33.00%
Return on Capital (ROIC)	-57.06%	-58.20%	-43.76%	-35.53%	-27.58%	-38.53%
Return on Capital Employed (ROCE)	-300.90%	-250.50%	-115.90%	-75.50%	-37.10%	-36.80%
Earnings Yield	-10822666.67%	-119.58%	-59.60%	-72.54%	-21.45%	-20.43%
FCF Yield	-6977333.33%	-96.63%	-46.29%	-50.60%	-16.64%	-15.48%
Buyback Yield / Dilution	-289.32%	-368.30%	-1.69%	-12.76%	-77.04%	-209.68%

Updated Oct 28, 2011. Source: S&P Global Market Intelligence. Standard template. Financial Sources.